Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Medgenics presents positive data from phase I/II Epodure trial in anemia

Feb. 3, 2009

New DPP-4 inhibitors discovered by Santhera and Biovitrum researchers

Feb. 3, 2009

Auxilium completes enrollment in phase IIb Xiaflex trial

Feb. 3, 2009

New CaSR antagonists discovered by Pfizer researchers

Feb. 3, 2009

GlaxoSmithKline divulges new calcium receptor antagonists for osteoporosis

Feb. 3, 2009

Patient recruitment resumes in FibroGen's phase II oral FG-4592 trial

Feb. 2, 2009

Betagenon initiates U.K. investigational medicinal product-enabling studies for BG-8702

Feb. 2, 2009

Bristol-Myers Squibb imparts glucokinase activators for type 2 diabetes

Feb. 2, 2009

Zavesca receives E.U. approval for treatment in Niemann-Pick type C disease

Jan. 30, 2009

Lipoxen reports interim results for long-acting erythropoietin candidate

Jan. 30, 2009

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 21, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
‘Detargeted’ targeted gene therapy improves activity in Pompe
BioWorld
A new strategy aims to improve gene therapy for Pompe disease by optimizing both the genetic component that restores the function of a deficient lysosomal enzyme...
WHO declares Ebola outbreak a public health emergency of international concern
BioWorld
The threat posed by the Ebola outbreak in the Democratic Republic of Congo has intensified, with the confirmation that it is caused by the Bundibugyo species of...
Nxera Pharma prepares and tests new GPR17 antagonists
BioWorld Science
Nxera Pharma UK Ltd. has identified new uracil nucleotide/cysteinyl leukotriene receptor (GPR17; P2Y-Like) antagonists potentially useful for the treatment of...